Effect of Modified Radial Artery Cannulation Site on IABP Monitoring Stability

March 13, 2026 updated by: SanQing Jin, Sixth Affiliated Hospital, Sun Yat-sen University

The Impact of Modified Site for Radial Artery Cannulation on the Stability of Arterial Blood Pressure Monitoring

Invasive arterial blood pressure (IABP) monitoring is critical for perioperative and critically ill patients, yet traditional radial artery cannulation near the wrist joint is prone to catheter dysfunction (e.g., kinking, occlusion) due to positional changes, compromising accuracy and patient safety. This trial hypothesizes that modifying the cannulation site to 1.5-2.5 cm proximal to the radial styloid process may enhance catheter stability.

Study Overview

Detailed Description

Methods and analysis:This is a prospective, parallel-group, randomized, controlled, analyst-blinded trial. A total of 486 participants (231 per group, adjusted for 5% dropout) will be enrolled. Eligible patients (18-75 years, ASA physical status I-III, requiring elective surgery with radial artery cannulation) will be randomized 1:1 to the modified group (1.5-2.5 cm proximal to the radial styloid process) or the conventional group (traditional site). The primary outcome is the incidence of arterial catheter dysfunction (defined by criteria such as blood sampling difficulty, position-dependent waveform, or improved waveform post-square wave test). Secondary outcomes include frequency of catheter dysfunction, damping abnormality rate, first-puncture success rate, number of arterial punctures,arterial cannulation time, complication incidence, and blood pressure measurement differences.

Sample size calculation:This trial utilized a superiority test for sample size calculation. In the 100-case preliminary experiment results, the incidence rate of abnormal arterial catheter function was 30% in the control group and 12% in the modified group. With a predefined superiority margin Δ of -6% (actual observed Δ of -18%), using a type I error rate (α) of 0.025 and statistical power (1-β) of 0.90, statistical calculations determined that 231 participants per group (totaling 462) would be required to detect this difference in a two-sided test. Considering a 5% dropout rate among study subjects, the final planned sample size was adjusted to 486 cases.

Study Type

Interventional

Enrollment (Actual)

486

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510655
        • The Sixth Affiliated Hospital, Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria

  1. Patients 18-75 years of age undergoing elective surgery who require radial artery cannulation;
  2. Patients positioned in supine, lithotomy, or other face-up surgical postures;
  3. American Society of Anesthesiologists (ASA) physical status classification: Grades I to III.

Exclusion criteria

  1. Abnormal results from the modified Allen test;
  2. Patients with a history of radial artery cannulation within the past 3 months, or with infection/trauma at or adjacent to the puncture site;
  3. Coagulopathy or hypercoagulable state;
  4. Patients undergoing anticoagulant therapy;
  5. Comorbid vascular diseases (e.g., vasculitis);
  6. Patients undergoing surgical procedures involving the same anatomic region;
  7. Preoperative hemodynamic instability (including patients already on vasoactive medications, or with atrial fibrillation, atrial flutter, atrioventricular block of grade II or higher, multifocal ventricular premature beats, or ventricular premature beats with R-on-T phenomenon);
  8. Patients lacking legal capacity to sign informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1.5-2.5 cm proximal to the radial styloid process
The ultrasound-guided radial artery puncture site is1.5-2.5 cm proximal to the radial styloid process
The ultrasound-guided radial artery puncture site is1.5-2.5 cm proximal to the radial styloid process
Active Comparator: traditional site
The ultrasound-guided radial artery puncture site is level with the radial styloid process and where the radial artery pulse is most prominent
The ultrasound-guided radial artery puncture site is level with the radial styloid process and where the radial artery pulse is most prominent

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of arterial catheter dysfunction
Time Frame: during the period of catheter indwelling
(a) difficulty in blood sampling: When drawing arterial blood samples for blood gas analysis, the sample cannot be aspirated smoothly through the arterial pressure monitoring line, necessitating repeated flushing of the line to obtain an adequate sample; or arterial catheter occlusion occurs and a new arterial pressure monitoring pathway must be established based on surgical or anesthetic requirements; (b) position-dependent waveform or flushing: repositioning of the arterial catheter or wrist is required to obtain a satisfactory arterial waveform, or smooth flushing can only be achieved following such repositioning. (c) improved waveform post-square wave test: after a square wave test (conducted every 30 minutes or when the arterial waveform becomes flat), the arterial waveform shows significant improvement compared to its pre-flush state.
during the period of catheter indwelling

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of arterial catheter dysfunction
Time Frame: during the period of catheter indwelling
mean number of catheter instability events per subject per hour.
during the period of catheter indwelling
Damping abnormality rate and frequency
Time Frame: during the period of catheter indwelling

Damping abnormality rate: the ratio of total cases with over-damping or under-damping to the total number of enrolled patients per group.

Damping abnormality frequency: mean number of over-damping or under-damping events per subject per hour.

during the period of catheter indwelling
First-puncture success rate
Time Frame: From the start of arterial puncture until successful arterial catheter placement or abandonment of the arterial catheter placement procedure,up to 10 minutes
the ratio of cases with successful first-time arterial cannulation to the number of enrolled cases per group. A successful first puncture is defined as achieving arterial access and catheter placement without needle withdrawal or repositioning after initial skin entry.
From the start of arterial puncture until successful arterial catheter placement or abandonment of the arterial catheter placement procedure,up to 10 minutes
Number of arterial punctures
Time Frame: From the start of arterial puncture until successful arterial catheter placement or abandonment of the arterial catheter placement procedure,up to 10 minutes
total number of arterial punctures performed before successful cannulation. One puncture is defined as withdrawing the needle to the subcutaneous layer and reinserting it during the cannulation process.
From the start of arterial puncture until successful arterial catheter placement or abandonment of the arterial catheter placement procedure,up to 10 minutes
Arterial Cannulation Time
Time Frame: From the start of arterial puncture until successful arterial catheter placement or abandonment of the arterial catheter placement procedure,up to 10 minutes
defined as the interval from the first skin entry of the needle to the first display of an arterial blood pressure waveform on the monitor.
From the start of arterial puncture until successful arterial catheter placement or abandonment of the arterial catheter placement procedure,up to 10 minutes
Complication incidence
Time Frame: from the time of the puncture onset until the time of every day after arterial puncture (at 1-day, 2-day, 3-day
encompasses complications during puncture and catheter indwelling (e.g., hematoma, bleeding, ecchymosis) and post-puncture complications (e.g., bleeding, hematoma, distal ischemia, local infection, peripheral nerve injury, unintended catheter dislodgment). The observation window is 0-3 days post-surgery.
from the time of the puncture onset until the time of every day after arterial puncture (at 1-day, 2-day, 3-day
Difference in IABP before and after square wave test.
Time Frame: during the period of catheter indwelling
The difference between the invasive blood pressure value before wave test and the invasive blood pressure value after waveform stabilization
during the period of catheter indwelling
Difference between IABP and NIBP
Time Frame: during the period of catheter indwelling
The difference between the invasive blood pressure value and the cuff pressure after waveform stabilization
during the period of catheter indwelling

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sanqing Jin, MD, The Sixth Affiliated Hospital, Sun Yat-sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2025

Primary Completion (Actual)

September 15, 2025

Study Completion (Actual)

November 27, 2025

Study Registration Dates

First Submitted

August 20, 2024

First Submitted That Met QC Criteria

August 20, 2024

First Posted (Actual)

August 22, 2024

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified participant data and statistical/analytic code will be available upon publication. Researchers who provide a methodologically sound proposal can request access by contacting Dr. Zhinan Zheng at zhengzhn5@mail.sysu.edu.cn. Data will be shared for specified purposes only and will require a signed data access agreement.

IPD Sharing Time Frame

Data will be available beginning 12 months after publication of the primary results and will remain accessible for 5 years.

IPD Sharing Access Criteria

Access is granted to researchers with a valid research proposal, ethical approval from their institution, and a signed data use agreement (DUA). Requests are reviewed by the trial's data access committee. Data use is limited to non-commercial, scientific research purposes.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perioperative Arterial Pressure Monitoring

Subscribe